Mitsubishi Chemical Group Corporation. (2/7/25). "Press Release: Notice Concerning the Transfer of Mitsubishi Tanabe Pharma
Corporation and its Subsidiaries
". |
2025-02-07 |
Bain Capital, LP. (2/7/25). "Press Release: Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation". Tokyo & Boston, MA. |
2025-02-07 |
Becton, Dickinson and Company. (2/5/25). "Press Release: BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value". Franklin Lakes, NJ. |
2025-02-05 |
Stryker. (1/28/25). "Press Release: Stryker Announces Definitive Agreement for the Sale of its U.S. Spinal Implants Business and Plans to Sell Related International Business". Portage, MI. |
2025-01-28 |
SGS S.A.. (1/15/25). "Press Release: Statement. Following Recent Media Commentary SGS Indicates that It Is in Discussions with Bureau Veritas Regarding a Potential Business Combination". |
2025-01-15 |
Umoja Biopharma, Inc.. (1/14/25). "Press Release: Umoja Biopharma Announces Oversubscribed $100 Million Series C Financing to Advance In Vivo CAR T Pipeline through Key Oncology Clinical Milestones". Seattle, WA. |
2025-01-14 |
BioMed X GmbH. (1/14/25). "Press Release: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy". Heidelberg. |
2025-01-14 |
Eckert & Ziegler SE. (1/14/25). "Press Release: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture". Berlin. |
2025-01-14 |
Bioptimus SAS. (1/14/25). "Press Release: Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology". |
2025-01-14 |
Eckert & Ziegler SE. (1/13/25). "Press Release: Eckert & Ziegler and GlyTherix Extend Collaboration with Actinium-225 Supply Agreement". Berlin & Sydney. |
2025-01-13 |
Daiichi Sankyo Co., Ltd.. (1/13/25). "Press Release: Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH". Tokyo & Basking Ridge, NJ. |
2025-01-13 |
Normunity, Inc.. (1/13/25). "Press Release: Normunity Closes $75 million Series B Financing to Advance Lead Drug Program into the Clinic and Broaden Pipeline of Novel Anti-cancer Therapies Targeting Untapped Drug Mechanisms". Boston, MA & New Haven, CT. |
2025-01-13 |
Candid Therapeutics, Inc.. (1/13/25). "Press Release: Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-cell Engager". New Brunswick, NJ & Bedminster, NJ. |
2025-01-13 |
Windward Bio AG. (1/10/25). "Press Release: Windward Bio Launches With $200 Million Series A Financing to Develop Phase 2-Ready, Long-Acting Anti-TSLP Antibody With Best-in-Class Potential in Asthma and COPD". Basel. |
2025-01-10 |
Innovent Biologics, Inc.. (1/2/25). "Press Release: Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate". San Francisco, CA & Suzhou. |
2025-01-02 |
BeiGene, Ltd.. (12/23/24). "Press Release: BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference". San Mateo, CA. |
2024-12-23 |
Innovent Biologics, Inc.. (12/20/24). "Press Release: Innovent Receives Approval of Dovbleron (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China’s National Medical Products Administration". San Francisco, CA & Suzhou. |
2024-12-20 |
Sangamo Therapeutics, Inc.. (12/19/24). "Press Release: Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases". Richmond, CA & Tokyo. |
2024-12-19 |
Innovent Biologics, Inc.. (12/16/24). "Press Release: Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca (pirtobrutinib) in Mainland China". San Francisco, CA, Indianapolis, IN & Suzhou. |
2024-12-16 |
Eckert & Ziegler SE. (12/13/24). "Press Release: Eckert & Ziegler Submits GalliaPharm for Approval by Japan’s Health Authority MHLW". Berlin. |
2024-12-13 |
Syncell, Inc.. (12/11/24). "Press Release: Syncell Announces $ 15 Million Series A Funding To Accelerate The Global Commercial Growth Of ITS Protein Purification And Spatial Proteomics Technology". Taipei & Watertown, MA. |
2024-12-11 |
Formycon AG. (12/9/24). "Press Release: MS Pharma Becomes Partner for the Commercialization of FYB202 / Ustekinumab in the MENA Region". Planegg-Martinsried. |
2024-12-09 |
Ion Opticks Pty Ltd.. (12/5/24). "Press Release: IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-quality Proteomic Insights". Melbourne. |
2024-12-05 |
Medigene AG. (11/26/24). "Press Release: Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment". Basel. |
2024-11-26 |
Adragos Pharma GmbH. (11/25/24). "Press Release: Adragos Pharma Acquires Baccinex – a Leading Swiss Sterile Fill-Finish Expert". Munich & Courroux. |
2024-11-25 |
Agilent Technologies Inc.. (11/25/24). "Press Release: Agilent Announces New Organizational Structure to Support its Market-Focused Strategy". Santa Clara, CA. |
2024-11-25 |
Agilent Technologies Inc.. (11/25/24). "Press Release: Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results". Santa Clara, CA. |
2024-11-25 |
[iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
BioNTech SE. (11/13/24). "Press Release: BioNTech to Acquire Biotheus to Boost Oncology Strategy". Mainz. |
2024-11-13 |
Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel. |
2024-11-12 |
Ion Opticks Pty Ltd.. (10/25/24). "Press Release: Sciex and IonOpticks Announce Co-Marketing Agreement Between Aurora Series XS Range and the ZenoTOF Line". Melbourne. |
2024-10-25 |
|transkript [Kääb, Georg]. (10/21/24). "Miltenyi Biotec: An Exclusive, Rare Interview with Founder Stefan Miltenyi. Interview by |transkript.de/Georg Kääb". |
2024-10-21 |
Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing
> Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA. |
2024-10-16 |
Innovent Biologics, Inc.. (10/8/24). "Press Release: Innovent and Ask Pharm Announce Strategic Collaboration for Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer". San Francisco, CA & Suzhou. |
2024-10-08 |
Yumab GmbH. (10/8/24). "Press Release: Yumab and Molcure Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets". |
2024-10-08 |
Mérieux NutriSciences Corporation. (10/7/24). "Press Release: Mérieux NutriSciences Enters Agreement to Acquire Worldwide Food Testing Business of Bureau Veritas". Chicago, IL. |
2024-10-07 |
Kurma Partners. (10/3/24). "Press Release: Kurma Partners Achieves First Close of New EUR 250 Million Biofund IV". Paris. |
2024-10-03 |
Regor Pharmaceuticals (USA). (9/30/24). "Press Release: Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of Next-generation CDK Inhibitors for the Treatment of Breast Cancer". Cambridge, MA. |
2024-09-30 |
Tempus AI, Inc.. (9/26/24). "Press Release: Tempus Announces Expansion of Collaboration with Takeda to Leverage Multimodal Real-world Datasets and Biological Model Systems in Oncology Research and Development". Chicago, IL. |
2024-09-26 |
Minaris Regnerative Medicine GmbH. (9/24/24). "Press Release: Minaris Regenerative Medicine Announces Agreement to be Acquired by Altaris". Yokohama, Munich & Allendale, NJ. |
2024-09-24 |
Aptadir Therapeutics. (9/24/24). "Press Release: Launch of Aptadir Therapeutics With a Novel Class of RNA Inhibitors". Milan. |
2024-09-24 |
Resonac Corporation. (9/24/24). "Press Release: Resonac Corporation Signs Contract to Transfer Shares of Minaris Regenerative Medicine Subsidiaries to Altaris". Zwingenberg. |
2024-09-24 |
Symrise AG. (9/20/24). "Press Release: Symrise and Shan Foods Inaugurate a State-of-the-Art International Standard Production Facility for Its Strategic Partnership in Pakistan". Dubai, Holzminden & Karachi. |
2024-09-20 |
Bioké (Cell Signaling Technology Europe B.V.). (9/16/24). "Press Release: Bioké and e-Blot Announce a Distribution Agreement in the European Region". Leiden. |
2024-09-16 |
Organon & Co.. (9/12/24). "Press Release: Organon Enters into Licensing Agreement with Bao Pharmaceutical and Its Wholly-owned Subsidiary Centergene Pharmaceuticals". Shanghai. |
2024-09-12 |
Abolis Biotechnologies SAS. (9/12/24). "Press Release: Abolis Biotechnologies Secures 35 Mio. Euro from International Consortium of Industrials and Funds". Èvry-Courcouronnes. |
2024-09-12 |
Singleron Biotechnologies. (9/11/24). "Press Release: Singleron Launches New All-in-One sCelLiVE Tissue Dissociation Kit for Skin". Cologne. |
2024-09-11 |
PhoreMost Ltd.. (9/10/24). "Press Release: PhoreMost Extends Series B Financing to $50M to Advance High-value Oncology and Inflammation Degrader Programmes". Cambridge. |
2024-09-10 |
Ion Opticks Pty Ltd.. (9/10/24). "Press Release: IonOpticks Partners with Adelis to Accelerate Global Expansion and Innovation". Melbourne & Stockholm. |
2024-09-10 |
Oxford Nanopore Technologies plc. (9/10/24). "Press Release: Oxford Nanopore Seeks Discovery in Connection with Anticipated Breach of Contract Action". |
2024-09-10 |
Candid Therapeutics, Inc.. (9/9/24). "Press Release: Candid Therapeutics Debuts with $370M Capital Raise to Clinically Evaluate Potentially Transformative Autoimmune Therapies". San Diego, CA. |
2024-09-09 |
Körber Pharma. (9/4/24). "Press Release: Körber Reaches Strategic Partnership with Taibang Biologic to Future-proof Blood Product Manufacturing and Increase Production Efficiency". Lüneburg & Tai’an. |
2024-09-04 |
EpimAb Biotherapeutics, Inc.. (9/4/24). "Press Release: EpimAb Biotherapeutics and Vignette Bio Announce Strategic Collaboration to Develop EMB-06, a BCMA×CD3 Bispecific Antibody". Shanghai & San Diego, CA. |
2024-09-04 |
eGenesis Inc.. (9/4/24). "Press Release: eGenesis Raises $191 Million Series D Financing to Advance Lead Program for Kidney Transplant". Cambridge, MA. |
2024-09-04 |
Nxera Pharma Co., Ltd.. (9/2/24). "Press Release: Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568". Tokyo & Cambridge. |
2024-09-02 |
Boehringer Ingelheim. (8/30/24). "Press Release: Boehringer Ingelheim Announces Appointments Board of Managing Directors". Ingelheim. |
2024-08-30 |
BioArctic AB. (8/22/24). "Press Release: Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain". Stockholm. |
2024-08-22 |
Coulter Partners. (8/22/24). "Press Release: Coulter Partners Places Industry Veteran Dr. David Hung as Chair of T-Therapeutics". |
2024-08-22 |
Vandria S.A.. (8/21/24). "Press Release: Hevolution Foundation and Dolby Family Ventures Join Vandria’s 2nd Series A Closing, Bringing the Total round to $30.7M (CHF 28.3M) to Progress the Mitophagy Inducer VNA-318 into CNS Clinical Development". Lausann |
2024-08-21 |
Fujifilm Diosynth Biotechnologies UK Ltd.. (8/20/24). "Press Release: Fujifilm Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility". Billingham. |
2024-08-20 |
Adcendo ApS. (8/20/24). "Press Release: Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor". Copenhagen & Shanghai. |
2024-08-20 |
BioNTech SE. (8/19/24). "Press Release: Lift of Partial Clinical Hold for BNT326/YL202". |
2024-08-19 |
Medigene AG. (8/8/24). "Press Release: Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers". Planegg-Martinsried. |
2024-08-08 |
PL BioScience GmbH. (8/8/24). "Press Release: PL BioScience Closes € 7.8 million Series A Financing". Aachen. |
2024-08-08 |
AGC Biologics. (8/7/24). "Press Release: NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines". |
2024-08-07 |
Leon-Nanodrugs GmbH. (8/6/24). "Press Release: Leon-Nanodrugs Secures Funds in a Series D Financing to Broaden Portfolio in First Single-use High Throughput Production Systems for Nanoencapsulation". Munich. |
2024-08-06 |
Biomatter Designs. (8/5/24). "Press Release: Biomatter Raises a €6.5 Million Seed Round to Unlock the Power of Generative AI for Enzyme Design". Vilnius. |
2024-08-05 |
iotaSciences Ltd.. (7/31/24). "Press Release: iotaSciences Raises Equity Financing Round to Drive further Business Expansion for Its Automated Single-cell Biology Handling Technologies". Oxford. |
2024-07-31 |
Systasy Bioscience GmbH. (7/31/24). "Press Release: Systasy Bioscience Announces Collaboration Agreement with Ono Pharmaceutical". Munich. |
2024-07-31 |
AIRNA Corporation. (7/31/24). "Press Release: AIRNA Raises Oversubscribed $60 Million Financing to Advance New Class of RNA Editing Medicines and Progress Best-in-Class AATD Program into the Clinic". Cambridge, MA & Tübingen. |
2024-07-31 |
Shenzhen Synthetica Pioneering Co., Ltd.. (7/30/24). "Press Release: Synthetica Pioneering Closes a Series A Funding Round to Support Development of Oncolytic Bacterial Therapy for Solid Tumors". Shenzhen. |
2024-07-30 |
65LAB. (7/29/24). "Press Release: 65LAB and Duke-NUS Award US$1.85 Million to Combat Chronic Inflammation". Singapore. |
2024-07-29 |
Innovent Biologics, Inc.. (7/26/24). "Press Release: Innovent and WeComput Announce Strategic Partnership to Advance AI-Driven Drug Discovery and Development". San Francisco, CA & Suzhou. |
2024-07-26 |
Revir Therapeutics. (7/26/24). "Press Release: Revir Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders". Brisbane, CA. |
2024-07-26 |
Pinetree Therapeutics, Inc.. (7/23/24). "Press Release: Pinetree Therapeutics Announces Exclusive Option and Global License Agreement for Preclinical EGFR Degrader Candidate with AstraZeneca". Cambridge, MA. |
2024-07-23 |
Triastek, Inc.. (7/23/24). "Press Release: Triastek Announces Research Collaboration and Platform Technology License Agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics". Nanjing. |
2024-07-23 |
TME Pharma N.V.. (7/22/24). "Press Release: TME Pharma Announces Strategic Plan to Externalize and Monetize Second Clinical Stage Asset NOX-E36". Berlin. |
2024-07-22 |
Valneva S.E.. (7/22/24). "Press Release: CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine". Oslo & Saint-Herblain. |
2024-07-22 |
CytoReason Ltd.. (7/17/24). "Press Release: CytoReason Secures $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to Scale Its AI Disease Models and Establish US Hub in Cambridge, Massachusetts". Tel Aviv. |
2024-07-17 |
Full-Life Technologies. (7/17/24). "Press Release: Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors". Heidelberg & Seoul. |
2024-07-17 |
Draupnir Bio ApS. (7/1//24). "Press Release: Draupnir Bio Completes €12 Million Seed Round to Progress Development of Oral Small Molecule Degraders of Extracellular Proteins". Copenhagen. |
2024-07-17 |
Scorpion Therapeutics, Inc.. (7/16/24). "Press Release: Scorpion Therapeutics Announces $150 Million Series C Financing to Advance Leading Clinical-stage Precision Oncology Pipeline". Boston, MA. |
2024-07-16 |
Catalym GmbH. (7/16/24). "Press Release: Catalym Announces New Financing of $150M to Support Broad Phase 2b Development Program for Visugromab". Munich. |
2024-07-16 |
Huma Therapeutics Ltd.. (7/16/24). "Press Release: Huma Completes Series D with Total Financing of over $80m as It Launches Huma Cloud Platform with GenAI Integrations to Bring Digital First Care and Research to Everyone". London & New York, NY. |
2024-07-16 |
Sotio Biotech a.s.. (7/16/24). "Press Release: Sotio Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline". Prague & Beijing. |
2024-07-16 |
Element Biosciences, Inc.. (7/11/24). "Press Release: Element Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth". San Diego, CA. |
2024-07-11 |
Ipsen S.A.. (7/11/24). "Press Release: Ipsen and Foreseen Biotechnology Announce Exclusive Global Licensing Agreement for Antibody-Drug Conjugate with First-in-Class Potential". Paris. |
2024-07-11 |
Endoron Medical Ltd.. (7/9/24). "Press Release: Endoron Medical Raises $10 Million in Series A Funding Led by Sofinnova Partners to Accelerate the Validation of Its AAA EndoStapling Solution Aortoseal". Tel Aviv. |
2024-07-09 |
Myricx Pharma Ltd.. (7/8/24). "Press Release: Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development". London. |
2024-07-08 |
Full-Life Technologies. (7/3/24). "Press Release: Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer". Heidelberg. |
2024-07-03 |
Sartorius AG. (7/2/24). "Press Release: Sartorius AG – After more than 20 Years as CEO, Joachim Kreuzburg Will Not Pursue another Term in Office – Supervisory Board Expresses Great Regret". Göttingen. |
2024-07-02 |
Proscia Inc.. (6/25/24). "Press Release: Proscia and Nucleai Partner to Broaden Access to AI Predictive Biomarkers". Philadeliphia, PA & Chicago, IL. |
2024-06-25 |
BioNTech SE. (6/24/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer". Mainz & Shanghai. |
2024-06-24 |
Iambic Therapeutics Inc.. (6/18/24). "Press Release: Iambic Therapeutics Closes $50 million Series B Extension to Broaden its Pipeline of AI-Discovered Clinical Oncology Programs". |
2024-06-18 |
Ethris GmbH. (6/18/24). "Press Release: Cipla EU to Invest an Additional EUR 3 Million in Ethris". Mumbai & Munich. |
2024-06-18 |
Santhera Pharmaceuticals Holding AG. (6/18/24). "Press Release: Santhera Secures up to CHF 69 million in Royalty and Debt Financing to Fund Operations to Cash Flow Break-Even (Ad hoc announcement pursuant to Art. 53 LR)". Pratteln. |
2024-06-18 |
AbbVie Inc.. (6/13/24). "Press Release: AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease". North Chicago, IL & Beijing. |
2024-06-13 |
T-Therapeutics Ltd.. (6/12/24). "Press Release: T-Therapeutics Appoints Dr David Hung as Chairman". Cambridge. |
2024-06-12 |
Adcytherix SAS. (6/11/24). "Press Release: Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates". Marseille. |
2024-06-11 |
Macomics Ltd.. (6/10/24). "Press Release: Macomics Announces Appointment of Simon Dew as New Chief Business Officer". Edinburgh & Cambridge. |
2024-06-10 |